Today: 30 June 2026
Browse Category

NASDAQ:CABA 31 October 2025 - 4 May 2026

Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy

Shares of Cabaletta Bio Inc. surged roughly 32% late Monday, buoyed by news of early results from a small cell-therapy trial and the announcement of a $150 million stock sale that counted Eli Lilly among its participants. Trading hit $3.895 on strong volume, topping out intraday at $4.04, according to market data. Share sales tend to draw flak from biotech investors worried about dilution, but Cabaletta’s deal played out differently. The company sold 51.7 million shares at $2.90 apiece—the at-the-market price allowed under Nasdaq rules. Bain Capital Life Sciences, Adage Capital Management, Cormorant Asset Management, along with fresh mutual and sovereign wealth funds, and Eli Lilly all took part.
4 May 2026
····
Biotech Boom: Cabaletta Bio’s CAR-T Trial Sparks 40% Stock Surge

Biotech Boom: Cabaletta Bio’s CAR-T Trial Sparks 40% Stock Surge

Cabaletta’s stock has been very volatile. From ~$2.40 on Oct 27 it briefly dipped to the $2.47 area by Oct 30, then exploded higher on Oct 31. Benzinga notes that CABA “rose 36.6% to $3.38” intraday on Oct 31benzinga.com; it eventually closed at $3.61stockanalysis.com. Over the week of Oct 25–31, CABA gained ~37%tradingview.com. For perspective, its 52-week range is roughly $0.99–$5.46stockanalysis.com. Technically, the stock is strongly overbought after the rally. On Oct 31 the 14-day RSI was ~84investing.com. All short-term moving averages sit well below the price, signaling strong upward momentum. Investing.com rates the technical picture as “Strong Buy”investing.com.
31 October 2025
··

Stock Market Today

  • Dell (DELL) Price Target Raised as AI Server Sales Fuel 23% Upside, Says 24/7 Wall St.
    June 30, 2026, 2:16 PM EDT. Dell Technologies (NYSE:DELL) stock could rally more than 20%, with 24/7 Wall St. putting a price target at $503, about 23% above the latest trade. That view follows a massive 757% jump in AI server revenue to $16 billion, which underpins a $43 billion AI backlog. Management raised fiscal 2027 revenue guidance on the back of those numbers. Gross margins dropped from 21% to 18% as more low-margin AI servers shipped, and supply chain issues tied to NVIDIA are a risk. Still, gross profit climbed 58% and operating income more than doubled. Dell shares are up 228% for the year and close to 52-week highs, driven by solid earnings and positive analyst calls. Margin compression remains a key worry for bears, but bulls say AI demand is driving the story.
Go toTop